Cerity Partners
MBOT icon

Cerity Partners’s Microbot Medical MBOT Stock Holding History

Cerity Partners’s Portfolio MBOT Stock Details MBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$20.7K Buy
10,635
+2
+0% +$4 ﹤0.01% 3364
2026
Q1 		$25.6K Buy
+10,633
New +$23.8K ﹤0.01% 3169

Other funds holding MBOT

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
DnB Asset Management
DnB Asset Management Oslo, Norway $35.7B AUM 27.58% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Cerity Partners's MBOT Position: Q2 2026 in Review

Cerity Partners increased its Microbot Medical (MBOT) stake by 0.02% in Q2 2026, buying an estimated $4 and bringing the position to 10,635 shares worth $20.7K. The position accounts for ﹤0.01% of the portfolio, ranked #3364.

Cerity Partners first reported a position in MBOT in Q1 2026 and has held it in 2 quarters since. The position peaked at $25.6K in Q1 2026. 71 funds tracked by Wall St. Rank hold MBOT as of Q2 2026.

  • Cerity Partners held 10,635 shares of Microbot Medical worth $20.7K as of Q2 2026.
  • Cerity Partners bought 2 Microbot Medical shares in Q2 2026, an estimated $4.
  • Microbot Medical made up ﹤0.01% of Cerity Partners's portfolio in Q2 2026, its #3364 holding.
  • Cerity Partners first reported a position in Microbot Medical in Q1 2026 and has held it in 2 quarters since.
  • Cerity Partners's Microbot Medical position peaked at $25.6K in Q1 2026.
  • 71 funds tracked by Wall St. Rank held Microbot Medical as of Q2 2026.

Based on Cerity Partners's 13F filing for Q2 2026, filed 14 Aug 2026.